US Patent 7183282 Substituted heterocycle fused γ-carbolines

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

71832820

Patent Inventor Names

Michael G. Yang0

Albert J. Robichaud0

Christopher D. McClung0

David M. Zawrotny0

Emilie J. Calvello0

Ian S. Mitchell0

Simon Haydar0

Taekyu Lee0

...

Date of Patent

February 27, 2007

Patent Application Number

113751250

Date Filed

March 14, 2006

Patent Citations Received

‌

US Patent 11957791 Methods

‌

US Patent 11958852 Compounds and methods

‌

US Patent 11980617 Methods of treating acute depression and/or acute anxiety

‌

US Patent 12023331 Methods

‌

US Patent 12070459 Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

‌

US Patent 12090155 Methods

‌

US Patent 12128043 Pharmaceutical capsules comprising lumateperone mono-tosylate

‌

US Patent 11680065 Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system

...

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

The present invention is directed to compounds useful for treating addictive behavior and sleep disorders represented by structural Formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7183282 Substituted heterocycle fused γ-carbolines

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7183282 Substituted heterocycle fused γ-carbolines